New Key Statistics Module, Z-Score and F-Score
AMEX:PLX Key Ratios
| Market Cap $ M | 156.10 |
| Enterprise Value $ M | 134.38 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 3.37 |
| Price/Book | 4.81 |
| Price/Sales | 3.67 |
| Price/Free Cash Flow | 24.94 |
| Price/Owner Earnings | 57.30 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 45.00 |
| EPS (TTM) $ | -0.16 |
| Beneish M-Score | -4.11 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -151.20 |
| EV-to-EBIT | -17.32 |
| EV-to-EBITDA | -20.75 |
| PEG | -- |
| Shares Outstanding M | 73.63 |
| Net Margin (%) | -21.04 |
| Operating Margin % | -19.50 |
| Pre-tax Margin (%) | -21.00 |
| Quick Ratio | 1.27 |
| Current Ratio | 1.98 |
| ROA % (ttm) | -11.58 |
| ROE % (ttm) | -29.54 |
| ROIC % (ttm) | -22.89 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.75 |
PLX Number of Guru Trades
PLX Volume of Guru Trades
Gurus Latest Trades with AMEX:PLX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:PLX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Protalix BioTherapeutics Inc Insider Transactions
No Available Data
News about AMEX:PLX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers